News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

QIAGEN N.V. (Nasdaq: QGENF) Invites You To Join Its Acquisition Of Key Assets Of Molecular Staging Inc.

10/19/2005 5:09:18 PM

VENLO, The Netherlands, Sept. 27 /PRNewswire-FirstCall/ -- In conjunction with QIAGEN's announcement of its acquisition of key assets of Molecular Staging, Inc., you are invited to listen to its conference call which will be broadcast live over the Internet on Monday, September 27, 2004 at 9:30 a.m. EDT, with Peer M. Schatz, President and Chief Executive Officer and Roland Sackers, Chief Financial Officer.

What: QIAGEN N.V. - Announcement of Acquisition of Key Assets of Molecular Staging, Inc. When: Monday, September 27, 2004 at 9:30 a.m. EDT Where: How: Live over the Internet -- Simply log on to the Web at the address above.

The corresponding presentation slides are available to download in the investor relations section of QIAGEN's website at:

Contact: Jane Petrino, Euro RSCG Life NRP, 212-845-4274

QIAGEN N.V., a Netherlands holding company with subsidiaries in Germany, the United States, Japan, the United Kingdom, Switzerland, France, Italy, Australia, Norway, Austria, Canada, and the Netherlands believes it is the world's leading provider of innovative enabling technologies and products for the separation, purification and handling of nucleic acids. QIAGEN has developed a comprehensive portfolio of more than 320 proprietary, consumable products for nucleic acid separation, purification and handling, nucleic acid amplification, as well as automated instrumentation, synthetic nucleic acid products and related services. QIAGEN's products are sold in more than 42 countries throughout the world to academic research markets and to leading pharmaceutical and biotechnology companies. In addition, QIAGEN is positioning its products for sale into developing commercial markets, including DNA sequencing and genomics, nucleic acid-based molecular diagnostics, and genetic vaccination and gene therapy. QIAGEN employs approximately 1,400 people worldwide. Further information on QIAGEN can be found at

(Minimum Requirements to listen to broadcast: The RealPlayer software, downloadable free from, or The Windows Media Player, downloadable free from and at least a 14.4Kbps connection to the Internet. If you experience problems listening to the broadcast, send an email to


CONTACT: Jane Petrino of Euro RSCG Life NRP, +1-212-845-4274, for QIAGENN.V.

Read at

comments powered by Disqus